• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

As CEO of the $96 billion Sam’s Club, Latriece Watkins is testing her mettle at the warehouse retailer that produced CEOs for Walmart, Target, and Walgreens

2

Jeff Bezos wants the bottom half of earners to pay zero income tax—he says nurses making just $75K should save $12K a year

3

As AI slashes white-collar jobs, Salesforce CEO Marc Benioff says almost no one is being hired—except in sales

1

As CEO of the $96 billion Sam’s Club, Latriece Watkins is testing her mettle at the warehouse retailer that produced CEOs for Walmart, Target, and Walgreens

2

Jeff Bezos wants the bottom half of earners to pay zero income tax—he says nurses making just $75K should save $12K a year

3

As AI slashes white-collar jobs, Salesforce CEO Marc Benioff says almost no one is being hired—except in sales
Healthobesity

How drugs like Ozempic and Wegovy work for weight loss: ‘Food tastes good, but I don’t want it’

By
Rachel Reiff Ellis
Rachel Reiff Ellis
Down Arrow Button Icon
By
Rachel Reiff Ellis
Rachel Reiff Ellis
Down Arrow Button Icon
July 1, 2023, 9:15 AM ET
Getty Images

For the scores of people seeing weight loss success on prescription injectables such as Ozempic, Wegovy, Saxenda, and others, the number on the scale isn’t the only change they’re experiencing. The “food noise” in their brains—the mental distraction of feeling compelled to eat—is also getting quieter.

Recommended Video

Robin, 49, from Baltimore, who is using her first name for privacy, started taking Ozempic in December of 2022 as a preventative measure against diabetes after she showed several signs of insulin resistance. Since then, she’s lost 20 pounds, her blood sugar and blood pressure have both stabilized—and her relationship to food has completely changed.

“I joke that the drug has taken away my last vices,” she says. “Food tastes good, but I don’t want it. I don’t crave anything, and sometimes I have to force myself to eat. The losing weight is awesome—the drug has definitely improved my numbers, like it was supposed to do. But it makes me a little sad since I enjoy food.”

So how exactly are these drugs hijacking the brain space formerly occupied by the siren song of snacks? By acting like chemical messengers and telling your brain you’re full.

How Ozempic and Wegovy work

Ozempic and Wegovy are in a class of drugs called glucagon-like peptide-1 agonists, or GLP-1 agonists. GLP-1 is a hormone your body makes naturally, one of several that helps regulate your appetite. It also decreases gastric emptying time, meaning food passes through your gut much more slowly, and stimulates and improves the release of insulin, which helps manage your blood sugar.

An agonist is a substance that binds to a receptor (a molecule that receives a signal) on or in a cell and causes the same action as the substance that normally binds to the receptor. In other words, these drugs act like the natural hormone GLP-1 and make your cells’ receptors send the exact same signal they would if they were binding to GLP-1 itself.

“It’s essentially hormone replacement for the hunger satiety signaling system that everyone has in their body that is supposed to regulate weight,” says Dr. Lydia Alexander, president-elect of the Obesity Medicine Association and chief medical officer for Enara Health. “When weight isn’t regulated properly by the body, we have obesity.”

How Ozempic and Wegovy quiet ‘food noise’

The GLP-1 your body makes gets degraded fairly quickly, but GLP-1 agonists stimulate their receptors for far longer. These receptors are in several different places in your body such as the gut and the liver, but the primary place of action is the brain, says Dr. Nisha Patel, obesity medicine specialist with Sutter Health in San Francisco.

“The body has mechanisms in place that are trying to fight that weight loss,” she says. “They’re saying, ‘No, I don’t really like this. I’m going to make you hungrier. I’m going to make it easier for you to want to see food.’ And so the medications are really there to help level the playing field, offset those changes that are happening, and make it easier for people to stick with healthy habits.”

But Patel emphasizes it’s not a quick fix—the medication is dosed upward slowly over several months—and for some people, it’s not a fix at all.

“There’s a lot of individual variability,” she says. “Not everybody responds as robustly. Some people don’t lose weight at all, and in fact, they gain weight. The lifestyle piece of it is still a very important foundation of our care. But medications are a really great tool for our patients to help them improve their health.”

Willpower doesn’t treat obesity

Many people are genetically predisposed to a deficiency in or resistance to GLP-1, which means they don’t get the same signals that other people get. It’s much harder for your body to regulate its hunger-satiety system when this is the case. But contrary to some societal messaging, the solution isn’t just to “try harder,” says Alexander.

“It feels as though it should be very simple, that if we just controlled ourselves a bit more and have more willpower, that we would get on top of this,” she says. “But this is a chronic relapsing condition, and our hormones are driving our behavior.”

It’s behavior human bodies have needed to survive, especially 10,000 years ago when food was scarce, says Alexander. But today, they’re sent for the wrong reason, creating a vicious circle.

“It becomes maddening—you reduce your weight and you’re feeling great about it, but the more you reduce your weight, the further away you get from your weight set point, which increases these signals, driving their behavior to go back and eat. And this is what ends up feeling like a personal failing, because you’re arm wrestling with your hormones, and they’re going to win.”

When combined with lifestyle changes, Ozempic and other drugs are highly effective for many people who take them, resulting in around 15% body weight loss on average. It’s a weight not only off their frame, but for many, their mind, too.

“Especially for my patients that have reward-seeking behavior and cravings, they’re not feeling like they’re constantly having to struggle and fight urges,” says Patel. “It’s pretty liberating.”

The Fortune 500 Innovation Forum will convene Fortune 500 executives, U.S. policy officials, top founders, and thought leaders to help define what’s next for the American economy, Nov. 16-17 in Detroit. Apply here.
About the Author
By Rachel Reiff Ellis
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.


Latest in Health

Gen Z is rejecting $200 dates and choosing ‘solo-maxxing’—and dating apps are taking a hit
Economydating
Gen Z is rejecting $200 dates and choosing ‘solo-maxxing’—and dating apps are taking a hit
By Sydney LakeMay 30, 2026
3 hours ago
Arianna Huffington warns Gen Z that no one with an ‘interesting job’ can simply shut their laptop at 5 p.m.—and if you can, you should change jobs
SuccessThe Promotion Playbook
Arianna Huffington warns Gen Z that no one with an ‘interesting job’ can simply shut their laptop at 5 p.m.—and if you can, you should change jobs
By Orianna Rosa RoyleMay 30, 2026
4 hours ago
America finally crushed smoking—then defunded the playbook
HealthTobacco
America finally crushed smoking—then defunded the playbook
By Mike Stobbe and The Associated PressMay 29, 2026
14 hours ago
Reverse Health App Review (2026): Our Honest Thoughts
HealthWorkouts
Reverse Health App Review (2026): Our Honest Thoughts
By Emily PharesMay 29, 2026
17 hours ago
Green Chef Review (2026): Opinions from Testers and Experts
Healthmeal delivery
Green Chef Review (2026): Opinions from Testers and Experts
By Christina SnyderMay 29, 2026
17 hours ago
Kenya suspends a U.S. plan to create a quarantine facility for Americans exposed to ebola
LawEbola
Kenya suspends a U.S. plan to create a quarantine facility for Americans exposed to ebola
By Evelyne Musambi and The Associated PressMay 29, 2026
1 day ago

Most Popular

As CEO of the $96 billion Sam’s Club, Latriece Watkins is testing her mettle at the warehouse retailer that produced CEOs for Walmart, Target, and Walgreens
Magazine
As CEO of the $96 billion Sam’s Club, Latriece Watkins is testing her mettle at the warehouse retailer that produced CEOs for Walmart, Target, and Walgreens
By Emma HinchliffeMay 27, 2026
3 days ago
Jeff Bezos wants the bottom half of earners to pay zero income tax—he says nurses making just $75K should save $12K a year
Success
Jeff Bezos wants the bottom half of earners to pay zero income tax—he says nurses making just $75K should save $12K a year
By Preston ForeMay 21, 2026
9 days ago
As AI slashes white-collar jobs, Salesforce CEO Marc Benioff says almost no one is being hired—except in sales
Success
As AI slashes white-collar jobs, Salesforce CEO Marc Benioff says almost no one is being hired—except in sales
By Emma BurleighMay 28, 2026
2 days ago
Current price of oil as of May 29, 2026
Personal Finance
Current price of oil as of May 29, 2026
By Joseph HostetlerMay 29, 2026
1 day ago
UBS says Ron DeSantis has a problem with his plan to help 92% of homeowners save on property taxes: His own state's data
Personal Finance
UBS says Ron DeSantis has a problem with his plan to help 92% of homeowners save on property taxes: His own state's data
By Nick LichtenbergMay 28, 2026
2 days ago
Researchers let AI models run a simulated society. Claude was the safest—and Grok committed 180 crimes and went extinct within 4 days
AI
Researchers let AI models run a simulated society. Claude was the safest—and Grok committed 180 crimes and went extinct within 4 days
By Jake AngeloMay 28, 2026
2 days ago